Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jirair Ratevosian

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|June 23, 2026
The Global Fund needs a more open search for its next leaderJirair Ratevosian
Lancet (London, England)|April 8, 2023
Legal and policy barriers for an effective HIV/AIDS responseJohn Nkengasong, Jirair Ratevosian
Lancet (London, England)|February 27, 2026
Fundamental PEPFAR reform risks a period of structural vulnerability in the HIV responseJirair Ratevosian, Chris Beyrer
BMJ (Clinical Research Ed.)|September 16, 2025
GLP-1 receptor agonists risk becoming another story of global health inequity-what can we learn from the response to HIV/AIDS?Jirair Ratevosian, Jeffrey L Sturchio
Academic Medicine : Journal of the Association of American Medical Colleges|October 28, 2009
Gathering in groups: peace advocacy in health professional associationsAmy Hagopian, Jirair Ratevosian, Emily deRiel
Journal of the International AIDS Society|February 25, 2025
By executive order: The likely deadly consequences associated with a 90-day pause in PEPFAR fundingKhai Hoan Tram, Jirair Ratevosian, Chris Beyrer
Lancet (London, England)|July 21, 2025
Recommitting to global solidarity: introducing the Kigali Call to ActionMumbi Chola, Jirair Ratevosian, Judith D Auerbach
Current Opinion in HIV and AIDS|September 2, 2025
Modeling the fallout: projecting the global impact of donor funding cuts on HIV prevention, treatment, and careJirair Ratevosian, Paul Ngangula, Khai Hoan Tram
Journal of the International AIDS Society|July 2, 2025
Leveraging existing market incentives to increase HIV pre-exposure prophylaxis access in the United StatesJirair Ratevosian, Caroline Piselli, Patrick Sullivan, et al.
AIDS (London, England)|August 4, 2025
The HIV/AIDS pandemic: where are we now?Chris Beyrer, Jirair Ratevosian, Huub Gelderblom, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|June 23, 2026
The Global Fund needs a more open search for its next leaderJirair Ratevosian
Lancet (London, England)|April 8, 2023
Legal and policy barriers for an effective HIV/AIDS responseJohn Nkengasong, Jirair Ratevosian
Lancet (London, England)|February 27, 2026
Fundamental PEPFAR reform risks a period of structural vulnerability in the HIV responseJirair Ratevosian, Chris Beyrer
BMJ (Clinical Research Ed.)|September 16, 2025
GLP-1 receptor agonists risk becoming another story of global health inequity-what can we learn from the response to HIV/AIDS?Jirair Ratevosian, Jeffrey L Sturchio
Academic Medicine : Journal of the Association of American Medical Colleges|October 28, 2009
Gathering in groups: peace advocacy in health professional associationsAmy Hagopian, Jirair Ratevosian, Emily deRiel
Journal of the International AIDS Society|February 25, 2025
By executive order: The likely deadly consequences associated with a 90-day pause in PEPFAR fundingKhai Hoan Tram, Jirair Ratevosian, Chris Beyrer
Lancet (London, England)|July 21, 2025
Recommitting to global solidarity: introducing the Kigali Call to ActionMumbi Chola, Jirair Ratevosian, Judith D Auerbach
Current Opinion in HIV and AIDS|September 2, 2025
Modeling the fallout: projecting the global impact of donor funding cuts on HIV prevention, treatment, and careJirair Ratevosian, Paul Ngangula, Khai Hoan Tram
Journal of the International AIDS Society|July 2, 2025
Leveraging existing market incentives to increase HIV pre-exposure prophylaxis access in the United StatesJirair Ratevosian, Caroline Piselli, Patrick Sullivan, et al.
AIDS (London, England)|August 4, 2025
The HIV/AIDS pandemic: where are we now?Chris Beyrer, Jirair Ratevosian, Huub Gelderblom, et al.
Pageof 3